Asciminib - Novartis
At a glance
- Drug Originator Novartis
- Drug Class Amides; Antineoplastics; Chlorinated hydrocarbons; Fluorinated hydrocarbons; Phenyl ethers; Pyrazoles; Pyridines; Pyrrolidines; Small molecules
- Mechanism of Action Bcr-abl tyrosine kinase inhibitors
- USA Patent Applicants NOVARTIS
- USA Patents 4
- NDAs 1
- International Patents 84
- Patent Applications 1
Table of Contents

Disclaimer